Compare Nokia Corp (NOK) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs 10X Genomics Inc — how do they compare? Nokia Corp trades at $11 (market cap $56.70B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Nokia Corp is far larger — about 10.3× 10X Genomics Inc's market cap, and Nokia Corp pays a 1.63% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| NOK | TXG | |
|---|---|---|
Market Cap | $56.70B | $5.48B |
Sector | Technology | Health |
52-Week High | $16.83 | $45.80 |
52-Week Low | $4.05 | $11.34 |
Enterprise Value | $53.51B | $5.02B |
Dividend Yield | 1.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
